Conversely, mutations in four p53-acetylation sites (K98R/K117R/K161R/K162R), rendered the quadruple-mutant p53 unable to regulate the expression of genes involved in ferroptosis, including SLC7A11, or to control tumor growth [267]. This evidence concerns the gene TP53 and neoplasm.